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Figure S1 Thermal ellipsoid drawing of L-H2Ph1 (hydrogen atoms except H(1), H(1A), H(2A) 
and H(4) are omitted for clarity; ellipsoids shown at 50% probability). 
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Figure S2 Thermal ellipsoid drawing of L-H2Ph1 (hydrogen atoms except H(1), H(1A), H(2A) 
and H(4) are omitted for clarity; ellipsoids shown at 50% probability). 
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Figure S3 Thermal ellipsoid drawing of complex TiPh3 showing one solvent molecule of 
toluene (hydrogen atoms are omitted for clarity; thermal ellipsoids are shown at 50% 
probability). F(1), F(2) and F(3) are modeled at 0.56 occupancy; F(1A), F(2A) and F(3A) are 
modeled at 0.44 occupancy; F(4), F(5) and F(6) are modeled at 0.52 occupancy; F(4A), F(5A) 
and F(6A) are modeled at 0.48 occupancy.
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 Table S1. Crystal data and structure refinement for L-H2Ph1, TiPh3, TaPh1, TaPh2 and 
TaPh3.
Compound L-H2Ph1 TiPh3 TaPh1 TaPh2 TaPh3
CCDC code 1970364 1970810 1970808 1970809 1970811
Formula C28H27NO3S C42H48F6N4O3STi C34H43N4O3STa C34H40F3N4O3STa C35H39F6N4O3STa
Formula weight 457.56 850.8 768.73 822.71 890.71
Temperature, K 293(2) 100(2) 100(2) 100(2) 100(2)
Wavelength, Å 0.71073 1.54178 0.71073 0.71073 1.54178
Space group P21 P212121 P212121 P212121 P212121
a, Å 9.1955(3) 8.1293(8) 13.3873(10) 10.0894(10) 8.8756(13)
b, Å 15.8730(5) 21.067(2) 15.0633(13) 11.9917(13) 11.4888(11)
c, Å 16.3458(5) 24.630(2) 16.5240(13) 28.308(3) 34.989(5)
 90 90 90 90 90
 92.775(3) 90 90 90 90
 90 90 90 90 90
Volume, Å3 2383.03(14) 4218.1(7) 3332.2(5) 3424.9(6) 3567.8(8)
Z 4 4 4 4 4
Density (calcd) 
Mg/m3 1.275 1.340 1.532 1.596 1.658
, mm-1 0.166 2.776 3.400 3.326 6.865
 range for data 
collection, °
1.8710 to 
24.1390°. 2.760 to 74.427°. 1.829 to 36.392°. 1.439 to 36.399°. 2.526 to 74.559°.
Reflections 




14398 8503 15757 16612 7123
Data / restraints / 
parameters 14398 / 1 / 603 8503 / 272 / 580 15757 / 267 / 450 16612 / 66 / 449 7123 / 0 / 457
Rint 0.0548 0.0479 0.0400 0.0496 0.0459
Final R indices 
[I>2(I)]
R1 = 0.0562, wR2 
= 0.0993
R1 = 0.0326, wR2 
= 0.0828
R1 = 0.0180, wR2 
= 0.0375
R1 = 0.0236, wR2 
= 0.0419
R1 = 0.0205, wR2 
= 0.0506
R indices (all data) R1 = 0.0947, wR2 = 0.1117
R1 = 0.0349, wR2 
= 0.0847
R1 = 0.0201, wR2 
= 0.0380
R1 = 0.0290, wR2 
= 0.0430
R1 = 0.0205, wR2 
= 0.0506
Goodness-of-fit on 
F2 1.016 1.037 0.993 1.016 1.082
Flack parameter -0.01(3) 0.056(3) 0.007(2) 0.012(2) 0.084(4)
Largest diff. peak 
and hole, e Å-3 0.30 and -0.28 0.487 and -0.219 0.533 and -1.202 0.928 and -1.624 0.494 and -1.376
Page S5
Figure S4 Thermal ellipsoid drawing of complex TaPh1 (hydrogen atoms are omitted for 
clarity; thermal ellipsoids are shown at 50% probability). C(21)-C(26) are modeled at 0.58 
occupancy; C(21A)-C(26A) are modeled at 0.42 occupancy. Selected bond distances (Å) and 
angles (°): Ta(1)-N(3) 1.9452(18), Ta(1)-N(4) 1.9558(17), Ta(1)-O(1) 1.9649(15), Ta(1)-N(2) 
1.9859(17), Ta(1)-N(1) 2.1952(15), N(3)-Ta(1)-N(4)112.57(8), N(3)-Ta(1)-O(1) 130.78(7), 
N(4)-Ta(1)-O(1) 116.32(7), N(3)-Ta(1)-N(2) 93.03(8), N(4)-Ta(1)-N(2) 95.72(7), O(1)-Ta(1)-
N(2) 87.69(7), N(3)-Ta(1)-N(1) 91.92(6), N(4)-Ta(1)-N(1) 101.48(6), O(1)-Ta(1)-N(1) 73.47(6), 
N(2)-Ta(1)-N(1) 158.68(7).
The geometry around the tantalum center in TaPh1 is best described as a distorted trigonal 
bipyramid with Rc(x) parameter of 9.39 for trigonal bipyramidal and 18.71 for square 
pyramidal.1 The  parameter is 0.47.2 The TBP axis is between the ligand nitrogen N(1) and the 
NMe2 nitrogen N(2) (Figure 3). One of the phenyl groups was disordered over two positions. 
Comparing to ligand structure in (Figure 1), the O-C-C-N dihedral angle reorients upon 
coordination to rotate the CPh2 group by approximately 120° bringing the oxygen into a five-
membered ring along with Ta(1), N(1), C(2), and C(1). The ArSO2 substituent on the 
sulfonamide also rotates away to prevent steric interactions between the tolyl group and the 
Ta(NMe2)3 portion of the molecule. 
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Figure S5 Thermal ellipsoid drawing of complex TaPh2 (hydrogen atoms are omitted for 
clarity; thermal ellipsoids are shown at 50% probability). F(1), F(2) and F(3) are modeled at 0.54 
occupancy; F(1B), F(2B) and F(3B) are modeled at 0.46 occupancy. Selected bond distances (Å) 
and angles (°): Ta(1)-N(3) 1.948(2), Ta(1)-N(4) 1.960(2), Ta(1)-O(1) 1.9705(17), Ta(1)-N(2) 
1.993(2), Ta(1)-N(1) 2.1720(19), N(3)-Ta(1)-N(4) 106.34(10), N(3)-Ta(1)-O(1) 137.55(8), N(4)-
Ta(1)-O(1) 116.03(8), N(3)-Ta(1)-N(2) 93.35(10), N(4)-Ta(1)-N(2) 96.56(9), O(1)-Ta(1)-N(2) 
84.67(8), N(3)-Ta(1)-N(1) 95.53(9), N(4)-Ta(1)-N(1) 102.11(9), O(1)-Ta(1)-N(1) 73.85(7), 
N(2)-Ta(1)-N(1) 156.12(8).
The geometry around the tantalum center in TaPh2 is best described as a distorted trigonal 
bipyramid with Rc(x) parameter of 11.35 for trigonal bipyramidal and 17.21 for square 
pyramidal.1 The  parameter is 0.31.2 The TBP axis is between the ligand nitrogen N(1) and the 
NMe2 nitrogen N(2). The CF3 group was disordered over two positions.
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Derivation of DOSY equations
Solutions of all eight Ti and Ta complexes were prepared in C6D6 and their diffusion 
constants were determined as an average value calculated from fits to the signal intensity for 
two regions of the spectra: an aryl signal and an NMe2 signal. Intensity was found to decay as a 
function of delay time according to the Stejskal-Tanner equation (eq. 1),3-4 where g is the 
gyromagnetic ratio, g is gradient strength, d and ∆ are delays and D is the diffusion constant. 







Hydrodynamic radii (rh) were calculated from the diffusion constants using the Stokes-
Einstein equation (equation 2), where kB is Boltzmann’s constant, and h is the solvent viscosity. 
These rh values are reported in Table 2. This derivation assumes spherical particles that are 
larger than the solvent molecules. Systematic errors in the calculated radii can be reasonably 







IR (diamond ATR) of L-H2Ph1
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1H NMR (400 MHz, CDCl3) of L-H2Ph2
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13C NMR (100 MHz, CDCl3) of L-H2Ph2
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IR (diamond ATR) of L-H2Ph2
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13C NMR (100 MHz, CDCl3) of L-H2Ph3
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IR (diamond ATR) of L-H2Ph3
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IR (diamond ATR) of L-H2Ph4
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1H NMR (400 MHz, C6D6) of TiPh1 {Ti(Ph1)(NMe2)2(HNMe2)}
Solvent peaks at 4.28 (CH2Cl2) 3.2 and 1.1 (Et2O)
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13C NMR (100 MHz, C6D6) of TiPh1 {Ti(Ph1)(NMe2)2(HNMe2)}
Solvent peaks at 53.4 (CH2Cl2) 65.9 and 15.6 (Et2O)
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13C NMR (100 MHz, C6D6) of TiPh2 {Ti(Ph2)(NMe2)2}
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Crude 1H NMR (400 MHz, C6D6) of TiPh3 {Ti(Ph3)(NMe2)2(HNMe2)}





























































































































































































































Ti ( NMe) 2( Ph3)  sol i d cr ude
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1H NMR (400 MHz, C6D6) of TiPh3·C7H8 {Ti(Ph3)(NMe2)2(HNMe2)·C7H8}
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13C NMR (100 MHz, C6D6) of TiPh3·C7H8 {Ti(Ph3)(NMe2)2(HNMe2)·C7H8}
Aromatic region
Full spectrum
Solvent peaks at 53.4 (CH2Cl2) 65.5 and 15.2 (Et2O)
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1H NMR (400 MHz, C6D6) of TiPh4 {Ti(Ph4)(NMe2)2}
Solvent peaks at 2.11, ~7.1 (toluene)
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13C NMR (100 MHz, C6D6) of TiPh4 {Ti(Ph4)(NMe2)2}
Peaks at 128.96 128.19 and 21.07 are due to residual toluene
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1H NMR (400 MHz, C6D6) of TaPh1 {Ta(Ph1)(NMe2)3}












































































































































































































































Ta( NMe2) 2( Ph1)  1H
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13C NMR (100 MHz, C6D6) of TaPh1 {Ta(Ph1)(NMe2)3}



























































































































































































Ta( NMe2) 2( Ph1)  13C
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1H NMR (400 MHz, C6D6) of TaPh2 {Ta(Ph2)(NMe2)3}
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1H NMR (400 MHz, C6D6) of TaPh3 {Ta(Ph3)(NMe2)3}
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13C NMR (100 MHz, C6D6) of TaPh4 {Ta(Ph4)(NMe2)3}
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DOSY NMR (400 MHz, C6D6) of TiPh1 {Ti(Ph1)(NMe2)2(HNMe2)}
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TiPh1 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Regi on 1 f r om 8. 155 t o 7. 959 ppm 
Di f f . Con. =5. 096E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TiPh2 {Ti(Ph2)(NMe2)2(HNMe2)}






















dosy day 3 ( l b nbk pg 34)
HPor t er _19_Jun_19  13  1  " C: \ HMC Chemi st r y\ ARJ"
TiPh2 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Peak 1 at  8. 026 ppm 
Di f f . Con. =4. 902E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TiPh3 {Ti(Ph3)(NMe2)2(HNMe2)}






















Ti  PH3 DOSY day 4 l bnbk pg 47
HPor t er _25_Jun_19  13  1  " C: \ HMC Chemi st r y\ ARJ"
TiPh3 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Peak 1 at  8. 591 ppm 
Di f f . Con. =5. 127E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TiPh4 {Ti(Ph4)(NMe2)2}
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TiPh4 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Regi on 1 f r om 7. 929 t o 7. 804 ppm 
Di f f . Con. =4. 593E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TaPh1 {Ta(Ph1)(NMe2)3}























FSi i i 101_DOSY  4  1  " C: \ HMC Chemi st r y\ ARJ"
TaPh1 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Peak 1 at  8. 037 ppm 
Di f f . Con. =5. 448E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TaPh2 {Ta(Ph2)(NMe2)3}






















TaPH2 DOSY ( pg 23 l ab nbk)
HPor t er _12_Jun_19  14  1  " C: \ HMC Chemi st r y\ ARJ"
TaPh2 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Peak 1 at  7. 921 ppm 
Di f f . Con. =5. 193E- 10m2/ S
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DOSY NMR (400 MHz, C6D6) of TaPh3 {Ta(Ph3)(NMe2)3}



















esj - 24- TaPh3DOSY  4  1  " C: \ HMC Chemi st r y\ ARJ"







[  *1e6] 0  10  20  30  40 
Diffusion : Variable Gradient
I=I[0]*exp(-D*SQR(2*PI*gamma*Gi*LD)*(BD-LD/3)*1e4)
Peak 1 at 8.545 ppm 
Diff.Con.=5.098E-10m2/S
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DOSY NMR (400 MHz, C6D6) of TaPh4 {Ta(Ph4)(NMe2)3}






















dosy day 2 ( l b nbk pg 28)
HPor t er _13_Jun_19  13  1  " C: \ HMC Chemi st r y\ ARJ"
TaPh4 DOSY fit plot
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Di f f usi on :  Var i abl e Gr adi ent
I =I [ 0] * exp( - D* SQR( 2* PI * gamma* Gi * LD) * ( BD- LD/ 3) * 1e4)
Peak 1 at  7. 492 ppm 
Di f f . Con. =5. 23E- 10m2/ S
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GC traces for the hydroamination of 6-methyl-hepta-4,5-dienylamine 1b at 135 °C with in situ 



























Hydroamination of hepta-4,5-dienylamine at 110 °C with in situ catalysts (5 mol% catalyst) to 
give tetrahydropyridine 2a, Z- or E--vinylpyrrolidines Z- and E-3a. Retention times are ± 0.3 



























TaPh4 (with and without impurity peak integration)
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